SEC INSIDER TRANSACTIONS

BIO-TECHNE Corp (TECH) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TECH · BIO-TECHNE Corp

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 32 filings · fetched 2026-11-13T20:19:21Z

Recent reported activity

0purchase rows on this page

0sale rows on this page

115matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-15Filed 2026-08-18	Herr Amy E.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. F2 Fully vested. F3 Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026. F4 Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. F5 Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F6 Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. F7 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F8 118 restricted stock units vest on 8/15/2026. F9 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. F11 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F12 Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. References: F7, F8	M Exercise / conversionRestricted Stock Units · Derivative	118D	0	IndirectBy significant other	Form 4 ↗0000914190-26-000113
2026-08-15Filed 2026-08-18	Herr Amy E.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. F2 Fully vested. F3 Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026. F4 Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. F5 Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F6 Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. F7 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F8 118 restricted stock units vest on 8/15/2026. F9 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. F11 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F12 Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	213D	72.4	IndirectBy significant other	Form 4 ↗0000914190-26-000113
2026-08-15Filed 2026-08-18	Herr Amy E.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. F2 Fully vested. F3 Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026. F4 Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. F5 Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F6 Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. F7 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F8 118 restricted stock units vest on 8/15/2026. F9 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. F11 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F12 Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	589A	0	IndirectBy significant other	Form 4 ↗0000914190-26-000113
2026-07-29Filed 2026-07-31	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F4 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F1	M Exercise / conversionStock Options (Right to Buy) · Derivative	62,068D	0	Direct	Form 4 ↗0000914190-26-000108
2026-07-29Filed 2026-07-31	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F4 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	51,024D	72.03	Direct	Form 4 ↗0000914190-26-000108
2026-07-29Filed 2026-07-31	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F4 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	62,068A	47.6	Direct	Form 4 ↗0000914190-26-000108
2026-07-28Filed 2026-07-30	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F4 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F5 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F6 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F7 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F9 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F12 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F1	M Exercise / conversionStock Option (Right to Buy) · Derivative	35,000D	0	Direct	Form 4 ↗0000914190-26-000106
2026-07-28Filed 2026-07-30	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F4 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F5 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F6 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F7 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F9 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F12 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	28,686D	72.07	Direct	Form 4 ↗0000914190-26-000106
2026-07-28Filed 2026-07-30	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F4 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F5 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F6 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F7 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F9 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F12 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	35,000A	47.6	Direct	Form 4 ↗0000914190-26-000106
2026-07-23Filed 2026-07-27	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024. F3 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F5 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F6 49 restricted stock units vest on 8/15/2026. F7 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References: F1	M Exercise / conversionStock Option (Right to Buy) · Derivative	448D	0	Direct	Form 4 ↗0000914190-26-000104
2026-07-23Filed 2026-07-27	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024. F3 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F5 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F6 49 restricted stock units vest on 8/15/2026. F7 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	344D	71.77	Direct	Form 4 ↗0000914190-26-000104
2026-07-23Filed 2026-07-27	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024. F3 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F5 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F6 49 restricted stock units vest on 8/15/2026. F7 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	448A	47.6	Direct	Form 4 ↗0000914190-26-000104
2026-06-02Filed 2026-06-04	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. F17 Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person. References: F1, F3	M Exercise / conversionRestricted Stock Units · Derivative	600D	0	Direct	Form 4 ↗0000914190-26-000096
2026-06-02Filed 2026-06-04	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. F17 Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person. References:	F WithholdingCommon Stock · Non-derivative	216D	49.77	Direct	Form 4 ↗0000914190-26-000096
2026-06-02Filed 2026-06-04	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. F17 Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person. References: F1, F17	M Exercise / conversionCommon Stock · Non-derivative	600A	—	Direct	Form 4 ↗0000914190-26-000096

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.